Cambridge Capital Group has over 80 members from a variety of backgrounds ranging from finance, technology and corporate to life sciences, agriculture and engineering. Members have invested in more than 60 live portfolio companies across Europe’s leading technology cluster since 2001. During 2016 members enjoyed four successful exits: Swiftkey, Cambridge CMOS, Oval Medical and Expedeon.
We are a syndicate member of the UK Business Angels Association (UKBAA) and our membership includes two UKBAA Investors of the Year.
We focus on businesses from Seed to Series A stage raising between £150k to £2m. We invest in B2B technology companies based on defensible intellectual property - companies meeting these requirements are invited to submit their summary using the link below.
As we continue to expand our network we invite new member applications from sophisticated investors, family offices and venture capital funds.